B
PPH icon

Baird’s VanEck Pharmaceutical ETF PPH Stock Holding History

Baird’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.35M Hold
19,255
– – 0.01% 663
2014
Q4 		$1.24M Buy
+19,255
New +$1.23M 0.01% 676
2014
Q3 		– Sell
-22,976
Closed -$1.43M – 1166
2014
Q2 		$1.43M Sell
22,976
-210
-0.9% -$12.5K 0.02% 578
2014
Q1 		$1.35M Buy
+23,186
New +$1.31M 0.02% 557

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Baird's PPH Position: Q1 2015 in Review

Baird held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2015 at 19,255 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #663.

Baird first reported a position in PPH in Q1 2014 and has held it in 4 quarters since. The position peaked at $1.43M in Q2 2014. 52 funds tracked by Wall St. Rank hold PPH as of Q1 2015.

  • Baird held 19,255 shares of VanEck Pharmaceutical ETF worth $1.35M as of Q1 2015.
  • Baird left its VanEck Pharmaceutical ETF share count unchanged in Q1 2015.
  • VanEck Pharmaceutical ETF made up 0.01% of Baird's portfolio in Q1 2015, its #663 holding.
  • Baird first reported a position in VanEck Pharmaceutical ETF in Q1 2014 and has held it in 4 quarters since.
  • Baird's VanEck Pharmaceutical ETF position peaked at $1.43M in Q2 2014.
  • 52 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.